Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: Not Listed | NSE: ZOTA

594.00
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  610.00
  •  610.00
  •  587.95
  •  604.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  27178
  •  163.10
  •  725.05
  •  400.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,538.80
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,538.63
  • 0.18%
  • 11.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.40%
  • 3.84%
  • 25.43%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 8.32%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.42
  • 13.66
  • 11.21

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.94
  • 10.88
  • -12.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.31
  • 4.14
  • -31.64

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 76.98
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.80
  • 10.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 105.55
  • 120.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
67.28
45.27
48.62%
56.30
38.65
45.67%
49.64
36.85
34.71%
46.93
34.97
34.20%
Expenses
68.15
40.85
66.83%
57.56
37.37
54.03%
51.12
35.82
42.71%
43.60
34.94
24.79%
EBITDA
-0.87
4.43
-
-1.26
1.28
-
-1.48
1.03
-
3.33
0.03
11,000.00%
EBIDTM
-1.29%
9.78%
-2.24%
3.31%
-2.99%
2.80%
7.10%
0.08%
Other Income
0.54
0.40
35.00%
0.02
0.15
-86.67%
0.46
0.03
1,433.33%
0.15
0.62
-75.81%
Interest
2.85
1.14
150.00%
2.90
0.83
249.40%
1.68
0.81
107.41%
1.14
0.71
60.56%
Depreciation
9.51
4.80
98.12%
8.02
3.41
135.19%
6.80
3.88
75.26%
5.08
3.30
53.94%
PBT
-12.69
-1.11
-
-12.16
-2.81
-
-9.51
-3.09
-
-2.73
-3.37
-
Tax
-0.51
0.54
-
0.56
0.03
1,766.67%
-2.59
-0.46
-
0.21
-0.14
-
PAT
-12.18
-1.65
-
-12.72
-2.84
-
-6.92
-2.63
-
-2.94
-3.23
-
PATM
-18.10%
-3.65%
-22.60%
-7.35%
-13.94%
-7.15%
-6.26%
-9.23%
EPS
-4.42
-0.64
-
-4.80
-1.13
-
-2.68
-1.05
-
-1.14
-1.28
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
220.15
180.43
139.91
131.17
106.77
95.11
85.63
Net Sales Growth
41.36%
28.96%
6.66%
22.85%
12.26%
11.07%
 
Cost Of Goods Sold
105.76
96.70
83.27
86.62
73.28
66.30
57.01
Gross Profit
114.39
83.72
56.64
44.55
33.48
28.81
28.62
GP Margin
51.96%
46.40%
40.48%
33.96%
31.36%
30.29%
33.42%
Total Expenditure
220.43
172.87
133.25
116.73
106.19
90.60
77.89
Power & Fuel Cost
-
2.31
1.35
0.94
0.77
0.68
0.61
% Of Sales
-
1.28%
0.96%
0.72%
0.72%
0.71%
0.71%
Employee Cost
-
29.24
12.15
9.48
8.56
9.59
8.02
% Of Sales
-
16.21%
8.68%
7.23%
8.02%
10.08%
9.37%
Manufacturing Exp.
-
2.69
1.72
2.35
1.96
1.79
1.83
% Of Sales
-
1.49%
1.23%
1.79%
1.84%
1.88%
2.14%
General & Admin Exp.
-
11.74
8.21
7.81
6.83
6.24
5.54
% Of Sales
-
6.51%
5.87%
5.95%
6.40%
6.56%
6.47%
Selling & Distn. Exp.
-
30.08
26.38
9.47
14.62
5.83
4.46
% Of Sales
-
16.67%
18.85%
7.22%
13.69%
6.13%
5.21%
Miscellaneous Exp.
-
0.12
0.16
0.07
0.16
0.18
0.41
% Of Sales
-
0.07%
0.11%
0.05%
0.15%
0.19%
0.48%
EBITDA
-0.28
7.56
6.66
14.44
0.58
4.51
7.74
EBITDA Margin
-0.13%
4.19%
4.76%
11.01%
0.54%
4.74%
9.04%
Other Income
1.17
1.16
2.62
1.99
1.31
1.52
1.54
Interest
8.57
4.79
2.56
0.32
0.11
0.07
0.04
Depreciation
29.41
20.09
11.96
3.67
3.17
2.10
1.39
PBT
-37.09
-16.16
-5.23
12.43
-1.39
3.86
7.86
Tax
-2.33
-1.82
1.08
3.53
-0.16
1.12
2.31
Tax Rate
6.28%
11.26%
-23.03%
28.40%
44.44%
29.02%
29.39%
PAT
-34.76
-14.35
-5.77
8.91
-0.21
2.74
5.55
PAT before Minority Interest
-34.68
-14.35
-5.77
8.91
-0.21
2.74
5.55
Minority Interest
0.08
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-15.79%
-7.95%
-4.12%
6.79%
-0.20%
2.88%
6.48%
PAT Growth
0.00%
-
-
-
-
-50.63%
 
EPS
-12.69
-5.24
-2.11
3.25
-0.08
1.00
2.03

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
89.98
80.36
89.63
66.30
68.83
68.93
Share Capital
25.85
25.16
25.16
24.56
24.56
17.54
Total Reserves
64.13
55.20
64.47
41.74
44.27
51.38
Non-Current Liabilities
60.26
36.12
13.35
0.95
1.05
0.87
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.50
0.98
1.04
0.94
0.87
0.76
Current Liabilities
73.68
40.52
35.96
18.23
18.60
19.81
Trade Payables
33.61
26.46
18.70
15.60
14.99
16.17
Other Current Liabilities
19.06
10.32
12.63
1.67
1.64
0.52
Short Term Borrowings
14.68
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
6.34
3.74
4.63
0.96
1.96
3.13
Total Liabilities
223.92
157.00
138.94
85.48
88.48
89.61
Net Block
102.70
62.08
29.10
14.08
15.41
9.78
Gross Block
145.79
85.08
47.91
29.93
28.09
20.36
Accumulated Depreciation
43.09
23.00
18.81
15.85
12.68
10.59
Non Current Assets
112.31
72.82
62.03
24.27
29.61
27.23
Capital Work in Progress
4.80
3.10
0.00
0.04
0.00
1.55
Non Current Investment
4.70
7.53
32.84
9.89
13.92
15.61
Long Term Loans & Adv.
0.11
0.11
0.09
0.27
0.28
0.29
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
111.62
84.17
76.90
61.21
58.86
62.37
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
53.77
41.79
28.95
28.18
25.34
32.51
Sundry Debtors
27.24
27.83
36.37
28.77
29.14
22.10
Cash & Bank
1.00
1.12
2.30
1.35
0.83
1.69
Other Current Assets
29.61
2.76
0.94
0.66
3.55
6.07
Short Term Loans & Adv.
21.84
10.68
8.35
2.25
3.27
3.54
Net Current Assets
37.93
43.65
40.94
42.98
40.27
42.56
Total Assets
223.93
156.99
138.93
85.48
88.47
89.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-5.98
-2.01
13.33
-0.89
5.56
-3.25
PBT
-16.16
-4.69
12.43
-0.37
3.86
7.86
Adjustment
23.69
13.12
2.66
1.45
1.06
0.01
Changes in Working Capital
-11.98
-8.29
1.97
-1.91
1.73
-8.79
Cash after chg. in Working capital
-4.45
0.13
17.07
-0.83
6.65
-0.93
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.53
-2.14
-3.73
-0.06
-1.10
-2.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12.90
14.70
-26.65
3.82
-3.54
8.83
Net Fixed Assets
-5.20
-4.41
-1.26
-1.79
-6.18
Net Investments
2.77
25.30
-24.85
4.04
1.59
Others
-10.47
-6.19
-0.54
1.57
1.05
Cash from Financing Activity
18.78
-13.88
14.27
-2.42
-2.87
-6.35
Net Cash Inflow / Outflow
-0.11
-1.18
0.95
0.51
-0.86
-0.77
Opening Cash & Equivalents
1.12
2.30
1.35
0.83
1.69
2.46
Closing Cash & Equivalent
1.00
1.12
2.30
1.35
0.83
1.69

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
34.81
31.94
35.62
26.99
28.02
28.06
ROA
-7.53%
-3.90%
7.94%
-0.24%
3.08%
6.19%
ROE
-16.85%
-6.79%
11.43%
-0.31%
3.98%
8.05%
ROCE
-12.30%
-2.50%
16.36%
-0.38%
5.71%
11.45%
Fixed Asset Turnover
1.56
2.10
3.37
3.68
3.93
4.21
Receivable days
55.69
83.71
90.61
98.96
98.30
94.19
Inventory Days
96.62
92.24
79.46
91.46
111.01
138.59
Payable days
113.36
98.97
72.26
76.17
85.77
72.36
Cash Conversion Cycle
38.95
76.98
97.82
114.25
123.54
160.41
Total Debt/Equity
0.16
0.00
0.00
0.00
0.00
0.00
Interest Cover
-2.38
-0.83
39.77
-2.33
56.64
214.47

News Update:


  • Zota Health Care gets registration licenses for two products in Myanmar
    4th Sep 2024, 14:41 PM

    The company shall commence export of these products in Myanmar

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.